Evidence map›Paper›PMID 33292053›Full record

ArticleThe Journal of international medical research2020

Expression and clinical significance of

Yi Jin, Tian-Xi Wang, Hao Li, Peng Guo, Qing-Qing Wang

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Yi JinDepartment of Oncology, Affiliated Xingtai People's Hospital of Hebei Medical University, Xingtai, P.R. China.
Tian-Xi WangSchool of Artificial Intelligence, Hebei University of Technology, Tianjin, P.R. China.
Hao LiDepartment of Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Peng GuoDepartment of Orthopedics, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
Qing-Qing WangDepartment of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China.ORCID https://orcid.org/0000-0003-3077-4843
Hebei Medical University · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNHebei University of Technology · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClear cell renal cell carcinoma (ccRCC) is a common urological disease. Expression of the protein tyrosine phosphatase 12 gene (

methodsWe detected PTPN12 protein expression in ccRCC and corresponding normal tissues from 64 patients with ccRCC by immunohistochemistry, and relative

resultsPTPN12 protein and mRNA expression levels were significantly lower in ccRCC compared with the corresponding normal tissues. The mRNA expression levels in the ccRCC and corresponding normal tissues from the 64 patients with ccRCC were 0.459±0.445 and 1.001±0.128, respectively, compared with the control (glyceraldehyde 3-phosphate dehydrogenase). There was a significant correlation between relative expression of

conclusionThe expression levels of PTPN12 protein and mRNA were significantly lower in ccRCC tissues compared with normal tissues. The role of PTPN12 may provide new insights and evidence to aid the diagnosis and targeted therapy of ccRCC.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsProtein Tyrosine Phosphatase, Non-Receptor Type 12Biomarkers, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisBiomarkers, TumorProtein Tyrosine Phosphatase, Non-Receptor Type 12PTPN12 protein, humanclear cell renal cell carcinomaimmunohistochemistrymRNAProtein tyrosine phosphatase 12PTPN12quantitative PCR

Identifiers

PMID33292053
PMCPMC7731720
OpenAlexW3112449356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.